ArticlePDF AvailableLiterature Review

Nutritional support after hospital discharge improves long-term mortality in malnourished adult medical patients: Systematic review and meta-analysis

Authors:

Abstract and Figures

Background & Aims In patients with malnutrition there is an increased long-term risk for mortality beyond the preciding hospital stay. We investigated the effects of postdischarge nutritional support in the outpatient setting on all-cause mortality in the populaton of malnourished medical patients in a systematic review of randomized controlled trials. Methods We searched MEDLINE and EMBASE, from inception to December 21, 2022. Randomized-controlled trials investigating nutritional support in medical patients following hospital discharge vs. control group (usual care, placebo and no nutritional support) were included. Data were independently extracted by two authors and were pooled using random effects model. Our primary outcome was all cause-mortality up to 12-months (end of intervention) of hospital discharge. Results We included 14 randomized-controlled trials with a total of 2,438 participants and mostly moderate trial quality. Compared to the control group, patients receiving outpatient nutritional support had lower mortality (13 trials, odds ratio [OR] 0.63, 95% confidence interval [CI] 0.48 to 0.84, p=0.001, I²=1%). Nutritional support was also associated with a significant increase in the mean daily intake of energy (568 kcal, 95% CI 24 to 1,113, p=0.04), proteins (24 g, 95% CI 7 to 41), p=0.005) and body weight (1.1 kg, 95% CI 0.6 to 1.7), p<0.001). No differences were found on hospital readmissions and handgrip strength. Conclusions This meta-analysis of randomized-controlled trials with mostly moderate trial quality suggests that nutritional support in the outpatient setting significantly increases nutritional intake as well as body weight, and importantly improves survival. Further large-scale and high-quality intervention trials are needed to confirm these findings.
Content may be subject to copyright.
Meta-analyses
Nutritional support after hospital discharge improves long-term
mortality in malnourished adult medical patients: Systematic review
and meta-analysis
Nina Kaegi-Braun
a
,
1
, Fiona Kilchoer
b
,
1
, Saranda Dragusha
c
,
1
, Carla Gressies
a
,
Montserrat Faessli
b
, Filomena Gomes
d
,
e
, Nicolaas E. Deutz
f
, Zeno Stanga
g
,
Beat Mueller
a
, Philipp Schuetz
a
,
*
a
Medical University Department, Clinic for Endocrinology/Metabolism/Clinical Nutrition, Kantonsspital Aarau, Aarau and Medical Faculty of the University
of Basel, Switzerland
b
Medical Faculty of the University of Basel, Switzerland
c
Medical Faculty of the Universit
a Della Svizzera Italiana, Switzerland
d
The New York Academy of Sciences, New York, NY, USA
e
NOVA Medical School, Universidade NOVA de Lisboa, Lisboa, Portugal
f
Center for Translational Research in Aging &Longevity, Department of Health &Kinesiology, Texas A&M University, College Station, TX, USA
g
Division of Diabetology, Endocrinology, Nutritional Medicine, &Metabolism, University Hospital Inselspital Bern, University of Bern, Bern, Switzerland
article info
Article history:
Received 2 May 2022
Accepted 21 September 2022
Key words:
Malnutrition
Outpatient
Post-discharge
Nutritional support
Nutritional therapy
summary
Background &aims: In patients with malnutrition there is an increased long-term risk for mortality
beyond the preciding hospital stay. We investigated the effects of postdischarge nutritional support in
the outpatient setting on all-cause mortality in the populaton of malnourished medical patients in a
systematic review of randomized controlled trials.
Methods: We searched MEDLINE and EMBASE, from inception to December 21, 2022. Randomized-
controlled trials investigating nutritional support in medical patients following hospital discharge vs.
control group (usual care, placebo and no nutritional support) were included. Data were independently
extracted by two authors and were pooled using random effects model. Our primary outcome was all
cause-mortality up to 12-months (end of intervention) of hospital discharge.
Results: We included 14 randomized-controlled trials with a total of 2438 participants and mostly mod-
erate trial quality. Compared to the control group, patients receiving outpatient nutritional support had
lower mortality (13 trials, odds ratio [OR] 0.63, 95% condence interval [CI] 0.48 to 0.84, p ¼0.0 01, I
2
¼1%).
Nutritional support was also associated with a signicant increase in the mean daily intake of energy
(568 kcal, 95% CI 24 to 1,113, p ¼0.04), proteins (24 g, 95% CI 7 to 41), p ¼0.005) and body weight (1.1 kg, 95%
CI 0.6 to 1.7), p <0.001). No differences were found on hospital readmissions and handgrip strength.
Conclusions: This meta-analysis of randomized-controlled trials with mostly moderate trial quality
suggests that nutritional support in the outpatient setting signicantly increases nutritional intake as
well as body weight, and importantly improves survival. Further large-scale and high-quality inter-
vention trials are needed to conrm these ndings.
©2022 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
1. Introduction
Disease-related malnutrition (DRM) is a syndrome associated
with increased morbidity, disability, short- and long-term mortal-
ity, impaired recovery from illness, and cost of care [1,2]. The
ndings of numerous randomized-controlled trials document that
nutritional care in the hospital setting improves survival and
clinical outcomes [3e5]. For this reason, current international
*Corresponding author. University Department of Medicine, Kantonsspital
Aarau, Tellstrasse, CH-5001, Aarau, Switzerland. Fax: þ41 (0)62 838 4100.
E-mail address: schuetzph@gmail.com (P. Schuetz).
1
Equally contributing rst authors.
Contents lists available at ScienceDirect
Clinical Nutrition
journal homepage: http://www.elsevier.com/locate/clnu
https://doi.org/10.1016/j.clnu.2022.09.011
0261-5614/©2022 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Clinical Nutrition 41 (2022) 2431e2441
guidelines recommend a proactive screening of patients at hospital
admission followed by individualized nutritional support during
the hospital stay in patients at risk [6,7].
However, malnutrition not only inuences hospital outcomes,
but also impacts long-term prognosis of patients. In fact, long-term
mortality associated with malnutrition is very high in multimorbid
medical patients [2,8]. A recent follow-up study of patients
included in the EFFORT trial [4] reported a substantial increase in 5-
year mortality risk related to more severe malnutrition, increasing
from approximately 50%e60% with a nutritional risk screening
(NRS 2002) score increase from 3 to 5 [2]. Nevertheless, the effects
of in-hospital nutritional support, which was stopped at hospital
discharge, did not show a legacy effect beyond 6 months [8].
While there has been strong research data regarding the
inhospital setting and short-term mortality, it remains unclear at
present whether continued nutritional support after hospital
discharge positively impacts survival in the long run. Some soci-
eties, for example the British Association for Parenteral and Enteral
Nutrition recommend to identify and consecutely treat patients
with malnutrition in the community setting [9]. However, due to
the paucity of conclusive evidence regarding long-term benetof
outpatient nutrition, lack of resources and nancial aspects,
nutritional support is often discontinued after discharge in clinical
practice without continuation in the community setting.
Herein, our aim was to investigate the association between post-
discharge nutritional support and clinical outcomes in hospitalized
medical patients at risk of malnutrition by doing a systematic
search and meta-analysis.
2. Methods
The methodology used for this meta-analysis followed a pre-
specied Cochrane protocol [10] and the Preferred Reporting Items
for Systematic Reviews and Meta-analyses (PRISMA) reporting
guidelines [11].
2.1. Data sources and searches
The literature searches were conducted in MEDLINE and EMBASE
databases. The last update was done in December 21st, 2021 and one
additionalstudywasidentiedand includedforanalysisin January 2022.
An example of the search strategy used in MEDLINE is provided
in the eMethods in the Supplement. In addition, we searched bib-
liographies of review articles and the ClinicalTrials.gov registry for
ongoing or unpublished trials. There were no language restrictions.
2.2. Study selection
We included RCTs investigating the effect of nutritional in-
terventions in malnourished or nutritionally at-risk adult patients
in the community setting after a hospitalization on medical wards.
The patients in the included RCTs were aged 18 years or older
and discharged home from a medical ward after they have been
identied as malnourished or at risk for malnutrition during
hospitalization.
Varios methods for malnutrition screening or assessment of
nutritional status were considered for inclusion, such as low body
mass index (BMI), signicant weight loss in recent months, a vali-
dated nutritional assessment or screening tool (e.g., Mini-
Nutritional Assessment (MNA), NRS-2002, Subjective Global
Assessment (SGA), Patient-Generated SGA (PG-SGA)). We only
included patients who were initially hospitalized in an acute care
institution on general medical wards or wards of any other medical
speciality (e.g., gastro-enterology, cardiology, pneumology, general
internal medicine, infectious diseases, nephrology, oncology).
We did not include trials focusing on surgical patients, intensive
care unit patients or patients under palliative care. If trials were
reporting results of mixed medical/surgical populations, we only
included those studies with at least 75% medical patients. If there
was no information about the distribution of medical/surgical pa-
tients we excluded the study. Focusing only on patients living at
home post hospital discharge, we also excluded trials carried in
nursing homes or long-term care facilities settings.
2.3. Types of interventions
Studies were eligible for inclusion if the intervention consisted
of any type of nutritional support such as: (a) dietary advice (in-
dividual dietary counselling to reach nutritional targets delivered
by dieticians through at-home visits or via telephone) (b) food
fortication (e.g. with protein powders), (c) oral nutrition supple-
ments (e.g. ready-to-drink-liquid, sip-feed), (d) snacks between
meals and (e) enteral tube feeding or anycombination of (a)-(e). We
did not include any trials with parenteral nutrition interventions,
neither in combination with other nutritional support nor exclu-
sively. Supplementation of specic vitamins (e.g. vitamin D) or
other micronutrients as well as hormonal therapies (e.g. testos-
terone) were not included in our analysis.
Interventions were initiated either during hospitalization or
after discharge and had to continue at least 2 weeks in the com-
munity setting.
Control group procedures were: (a) no nutritional support, (b)
usual care (nutritional management at the discretion of the treating
physician) or (c) placebo treatment.
In sensitivity analyses we stratied trials by the prespecied
subgroups setting, type and duration of intervention, as well as age
and admission diagnosis. There was a lack of trials with additional
physical activity and grading of malnutrition status, therefore, the
preplanned analysis was not possible. An exploratory subgroup
analysis on sex and protein content of the nutritional intervention
was implemented. Subgroup analysis was taken into consideration
if the amount of trials included in a subgroup were 3.
2.4. Outcomes
Our primary endpoint was all-cause mortality dened as death
from any cause at the end of the intervention (up to 1 year after
randomization). Secondary outcomes included non-elective read-
mission rates, hand grip strength as a functional outcome, changes
in anthropometric measurements (weight change, BMI), daily en-
ergy (kcal), and protein (g) intake. Additionally, we assessed
adverse events.
2.5. Data extraction and quality assessment
Each abstract was screened by two reviewers independently and
relevant data of studies meeting the inclusion criteria were
extracted by means of a standardized data extraction template.
Discrepancies were resolved through consensus or recourse to a
third review author. The reviewers also assessed risk for bias using
the criteria recommended by Cochrane Collaboration [10].
We tested two-sided with a signicance level of
a
¼0.05. Re-
view Manager version 5.4 (from the Cochrane Collaboration)
generated the gures and calculations.
2.6. Statistical analysis
2.6.1. Data synthesis and analysis
We expressed dichotomous data as odds ratios (ORs) or risk
ratios (RRs) with 95% condence intervals (CIs). Continuous data
N. Kaegi-Braun, F. Kilchoer, S. Dragusha et al. Clinical Nutrition 41 (2022) 2431e2441
2432
Table 1
Overview of included studies.
Source Country Journal Amount of
randomized
patients
Ward Patient
population
Setting of
intervention
Type of intervention Control
Gazzotti, C.,
2003 [17]
Belgium Age and Ageing 80 Geriatric 75 years, admitted for
acute conditions,
informed consent, at
risk of undernutrition
based on their initial
MNA score between 17
and 23.5
inhospital and
community
200 ml sweet or salty
sip feed twice daily
(500 kcal, 21 g protein
per day) throughout
hospitalization and
convalescence
usual care
Edington, J.,
2004 [23]
United Kingdom Clinical nutrition 100 Undened >65 years, to be
discharged from
hospital with either (i) a
BMI <20 kg/m
2
, or (ii)
BMI >20 but <25 kg/m
2
with documented
evidence of weight loss
of 10% of their body
weight in the 6 months
prior to the study
period or 5% in the 3
months prior to the
study, score 7 on the
Abbreviated Mental
Test
community different types of ONS usual care
Price, R., 2005
[18]
United Kingdom Gerontology 136 medical and geriatric BMI 24 kg/m
2
and
triceps skin fold
thickness (TSF) or mid-
arm muscle
circumference (MAMC)
below the 10th centile
and/or a weight loss
65% during hospital
stay, aged 75 years
community 2 servings of ONS/day
for 8 weeks
usual care
Feldblum, I.,
2010 [24]
Israel The American
Geriatrics Society
259 internal medicine 65 years, at
nutritional risk (MNA
less than 10), weight
loss of more than 10%
during the 6 months
before the study period
inhospital and
community
Dietary advice during
hospitalization and
post discharge, food
supplements, vitamins
and minerals if
necessary
usual care or
dietary advice once
during
hospitalization
Neelemaat, F.,
2011 [20]
Netherlands Journal of the
American Medical
Directors Association
210 general internal
medicine,
rheumatology,
gastroenterology,
dermatology,
nephrology,
orthopedics,
traumatology, and
vascular surgery
60 years of age,
expected length of
hospital admission >2
days, BMI of 20 kg/m
2
or lower and/or, 5% or
more unintentional
weight loss in the
previous month and/or
10% or more
unintentional weight
loss in the previous 6
months.
inhospital and
community
energy- and protein
enriched diet, two
additional servings of
ONS, calcium-
usual care
vitamin D supplement,
telephone counseling
by a dietitian for 3
months after discharge
(continued on next page)
N. Kaegi-Braun, F. Kilchoer, S. Dragusha et al. Clinical Nutrition 41 (2022) 2431e2441
2433
Table 1 (continued )
Source Country Journal Amount of
randomized
patients
Ward Patient
population
Setting of
intervention
Type of intervention Control
Beck, A. M.,
2013 [25]
Denmark Clinical Rehabilitation 152 Geriatric 65 years, at
nutritional risk
according to the level 1
screen in NRS 2002,
hospitalized for 2
days, BMI <20.5 kg/m
2
;
and/or weight loss
within the last 3
months; and/or a
reduced dietary intake
in the last week; and/or
serious ill (e.g. in
intensive therapy)
community three GP visits post
discharge plus three
visits of a dietician for
dietary counselling
three GP visits post
discharge, without
dietician
Beck A., 2015
[26]
Denmark Clinical rehabilitation 71 geriatric/orthopedic
ward
at nutritional risk,
receiving nutritional
support at the wards,
were planned to be
discharged to their
private home
community discharge Liaison-Team
in cooperation with a
dietician
- three home visits to
implement a
nutritional care plan
(dietary counselling,
subscription of ONS)
discharge Liaison-
Team without a
dietician
Deutz, N. E.,
2016 [3] and
Matheson,
M. E.,
2020*
16
USA Clinical nutrition 652 internal medicine >65 years, recent
hospital admission,
primary diagnosis of
CHF, AMI, PNA, or
COPD, SGA class of B or
C
inhospital and
community
2 servings/day of high
protein ONS (HP-HMB)
2 servings/day of
placebo
supplement
Bonilla-
Palomas, J. L.,
2016 [28]
Spain Archives of Medical
Research
120 Undened >18 years, hospitalized
for acute heart failure,
either decompensated
chronic heart failure or
new onset heart failure,
also presenting
malnutrition (MNA
score)
inhospital and
community
diet optimization,
specic
recommendations and
nutritional supplement
prescriptions
usual care
Andersson, J.,
2017 [21]
Norway J Nutr Health Aging 115 rehabilitation >18 years,
undernourished or at
risk of disease-related
malnutrition (>3 points
using the NRS 2002),
and residing in the
capital Oslo or the
nearby municipalities
of Asker or Bærum,
communicate in
Norwegian and to
provide written
informed consent
community Dietary advice,
individual nutritional
plan, three telephone
calls and one home visit
for nutritional
counselling
no nutritional
support after
discharge
Sharma, Y.,
2017 [19]
Australia QJM: An International
Journal of Medicine
148 acute medical >60 years,
malnourished by PG-
SGA (classes B and C)
inhospital and
community
individualized nutrition
care plan plus monthly
post-discharge
telehealth follow-up
usual care
N. Kaegi-Braun, F. Kilchoer, S. Dragusha et al. Clinical Nutrition 41 (2022) 2431e2441
2434
was expressed as mean differences (MDs) with 95% CIs and data
were pooled using random effects model.
Missing data was imputed following the Cochrane Handbook
[10], whenever possible and reasonable: we used the median to
estimate the mean in trials with more than 25 patients [12]. When
the variance was not given, it was estimated with the 95% CI [10,12].
To approximate the SD for the change in an outcome, we calculated
the mean from baseline and follow-up, when nothing else was
applicable.
2.6.2. Assessment of heterogeneity and publication bias
We identied heterogeneity (inconsistency) through visual in-
spection of the forest plots and considered the I
2
statistic, to assess
the impact of heterogeneity on the meta-analysis [13]. An I
2
statistic
of 50% or more indicates a substantial level of heterogeneity [14].
We used visual inspection of funnel plots to assess publication
bias. Owing to several possible explanations for funnel plot asym-
metry, we interpreted these results carefully [15].
3. Results
3.1. Systematic literature search
Our systematic literature search identied 293 titles and ab-
stracts of potentially eligible studies from electronic databases and
56 additional records through contact with experts, systematic
reviews/meta-analyses and handsearching of literature. After
duplicate removal, 310 records were screened, and 83 full texts
were assessed for eligibility. Of these, 14 trials with a total of 2438
randomized and 2330 analysed patients were included in the nal
meta-analysis. A ow chart is displayed ineFig. 3 in the Supplement.
Most included RCTs were single-centre and included heteroge-
neous adult medical or mixed medical/surgical inpatients. Studies
were conducted between 2004 and December 2021 in different,
mostly European, countries. Interventions were mainly oral feeding
strategies and dietary advice. None of the included studies per-
formed enteral tube feeding nor other, not pre-dened, in-
terventions (such as exercise). Control group patients were mostly
treated based on usual care. Only one trial used a placebo-
controlled intervention. Additional characteristics of included
RCTs are shown in Table 1.
3.2. Risk of bias assessment
There was a low or unclear risk of bias in most trials except for
performance bias because blinding of participants and personnel
regarding the nutritional interventions was not done in most
studies (eFigs. 1 and 2).
3.3. Primary outcome
Out of 14 included studies, 13 trials reported all-cause mortality
within 12 months while one study [16] analyzied only secondary
outcomes of a previous included trial [3]. The mortality in the
different RCTs varied from 0.9% to 34.2%. In the overall analysis,
there were 108/1060 (10.2%) deaths in the intervention group
compared to 170/1164 (14.6%) in the control group (OR 0.63, 95%CI
0.48 to 0.84, p ¼0.001). We found low heterogeneity among trials
(I
2
¼1%, p ¼0.44) (Fig. 1).
The time of outcome measurement was different among the
trials. The range of the observation period was 60 dayse360 days. If
there were multiple time points of mortality assessment, we
collected the mortality rate as close to a 180 days observation
period as possible. Mortality rates were shown at follow-up at 60
Yang, P. H.,
2019 [22]
Taiwan International Journal of
Environmental
Research and Public
Health
82 medical >65 years, primary
diagnosis of pneumonia
by a physician, and
malnutrition status
indicated by BMI
<18.5 kg/m
2
or MNA-SF
score 7
inhospital and
community
individualized
nutritional intervention
program
usual care
Munk, T., 2021
[27]
Denmark Clinical nutrition 207 oncology,
gastroenterology,
cardiology, medical
50 years, NRS3,
inhospital nutritional
support, ability to read,
hear and understand,
discharge to own home,
cognitively intact
inhospital and
community
individual dietary
counselling and an
individualized
nutritional plan from a
research assistant,
hand-out nutritional
information material,
food package, goodie
bag, electronical
communication to
municipality
usual care
Blondal, B.S.,
2021 [51]
Iceland Clinical Nutrition
ESPEN
106 geriatric 65 y, community
dwelling, discharge
home, risk for
malnutrition, living in
Reykjavik, MMSE20
community dietary counselling,
free supplemental
energy- and protein-
rich foods, ONS
usual care
MNA: Mini Nutritional Assessment, BMI: body mass index, ONS: oral nutritional supplement, NRS 2002: Nutritional Risk Screening 2002, GP: general practitioner, CHF: congestive heart failure, AMI: acute myocardial infarction,
PNA: pneumonia, COPD: chronic obstructive pulmonary disease, SGA: Subjective Global Assessment, HP-HMB: high-protein beta-hydroxy-beta-methylbutyrate, PG-SGA: Patient Generated Subjective Global Assessment, MNA-
SF: Mini Nutritional Assessment eShort Form, ESPEN: European Society for Clinical Nutrition and Metabolism, MMSE: Mini-Mental State Exam.
*
subgroup analysis.
N. Kaegi-Braun, F. Kilchoer, S. Dragusha et al. Clinical Nutrition 41 (2022) 2431e2441
2435
days [17], 84 days [18 ], 90 days [3,19e21], 180 days [22e27] and 360
days [28].
3.4. Secondary outcomes
3.4.1. Readmission rate
A total of 10 RCTs reported non-elective hospital readmissions
during a follow-up of 60 days [17], 3 months [3,18], 6 months
[19,22,25,26], or 12 months [28]. Two trials reported the read-
mission rates for one disease only (pneumonia [22], heart failure
[28]). We included those trials in our readmission-analysis without
any limitations. There was no signicant difference in readmission
rate between intervention and control (RR 0.89, 95% CI 0.74 to 1.07,
p¼0.22) (eFig. 4). The heterogeneity was moderate I
2
¼56%.
3.4.2. Functional outcome
A total of 4 RCTs reported functional outcome with measure-
ment of hand grip strength at 3 months [16,19,25,26]after
discharge (eFig. 5). There was no signicant difference in handgrip
strength between intervention and control group patients (MD
0.03, 95% CI -1.08 to 1.15, p ¼0.95). Heterogeneity was moderate
(I
2
¼62%).
One trial [20] reported the change in functional outcome only.
Other trials [18,23] performed measurements but did not provide
exact numbers.
3.4.3. Body weight, BMI and nutritional intake
A total of 9 RCTs reported a body weight change from baseline
measurements until follow-up at 60 days [17], 3 months
[18e20,25e27] and 6 months [23,24]. Compared with the control
group, the nutritional intervention was associated with a signi-
cant increase in body weight change (MD of weight change 1.14 kg,
95% CI 0.58 to 1.70, p <0.0001) at the time of outcome measure-
ment (Fig. 2). Patients in the nutritional intervention group
increased their weight an average of 1.17 kg, while the control
group had an average weight loss of 0.11 kg during the observa-
tion period. Heterogeneity was low (I
2
¼25%).
A total of 7 RCTs reported daily protein intake at 60 days [17], 3
months [25e27] or 6 months [22,29] after discharge. There was a
signicant increase in protein intake in the nutritional intervention
group (MD 24.26 g per day, 95% CI 7.18 to 41.34, p ¼0.005)
Fig. 1. Forest plot comparing nutritional intervention and control for mortality. A Mantel-Haenszel random-effects model was used. Squares indicate mean values, with the size of
squares reecting the weigth and the lines indicating 95% Cis. Diamonds indicate pooled estimates, with horizontal points of the diamonds indicating 95% CIs.
Fig. 2. Forest plot comparing nutritional intervention and control for change in body weight. A Mantel-Haenszel random-effects model was used. Squares indicate mean values,
with the size of squares reecting the weigth and the lines indicating 95% Cis. Diamonds indicate pooled estimates, with horizontal points of the diamonds indicating 95% CIs.
N. Kaegi-Braun, F. Kilchoer, S. Dragusha et al. Clinical Nutrition 41 (2022) 2431e2441
2436
compared with the control group (Fig. 3). The average protein
consumption per day among the patients in the nutritional inter-
vention group was 74 g and 49 g in the control group. Heteroge-
neity was high (I
2
¼98%). Fig. 4
There was a signicant difference in 6 trials reporting energy
intake at follow-up (at 60 days [17], 3 months [25e27], or 6 months
[22,29] after discharge) in the intervention group compared to the
control group (MD 568.06 kcals per day, 95% CI 23.56 to 1112.57,
p¼0.04) (eFig. 6). The average energy consumption per day among
the patients in the nutritional intervention was 1838 kcal and
1270 kcal in the control group. We imputed total energy intake in
the intervention group of one trial [17], because they reported the
energy intake from the ONS separately.
Furthermore 3 trials showed no signicant change in BMI (MD
0.18, 95% CI -0.75 to 1.11, I
2
¼68%, p ¼0.71) in the nutritional
intervention group compared to the control group after 3 months
[19] and 6 months [22,23] with moderate heterogeneity (I
2
¼68%)
(eFig. 7).
Only three trials [3,17,18] reported adverse outcomes in corre-
lation with the consumption of ONS (eTable 1 in the Supplement).
3.5. Sensitivity analyses
Table 2 provides an overview of the subgroup analysis.
3.5.1. Mortality
Regarding the effect of outpatient nutritional support on mor-
tality, there were only minor differences between the subgroups.
Three studies included patients with specic admission diagnosis
(cardiac and/or pulmonary). Compared to no specic admission
diagnosis in the remaining 10 studies (OR 0.83, 95% CI 0.59 to 1.18,
I
2
¼0%, p ¼0.30), these patient group showed a pronounced
benet from nutritional support (OR 0.43, 95% CI 0.28 to 0.68,
I
2
¼0%, p ¼0.0003) with a signicant p-value for subgroup dif-
ference 0.03.
4. Discussion
This systematic review and meta-analysis of RCTs investigating
the association of outpatient nutritional support with clinical out-
comes has three key ndings. First, post-discharge nutritional
support in medical patients at nutritional risk reduced long-term
mortality by 37%. Second, there were signicant and clinical rele-
vant effects on further secondary outcome such as body weight
change, protein intake and energy intake, respectively. And third,
there were some signicant effects in subgroup analyses stratied
for patients characteristics and type of nutritional intervention.
Most of the recently published literature about nutritional in-
terventions for malnourished patients include meta-analyses from
mixed health care settings (in- and outpatient) [30] or meta-
analyses focusing on inhospital interventions [5,31]. Today, there
is conclusive evidence that inhospital nutritional support improves
survival. However, until now, the evidence on the management of
DRM after hospitalisation in the outpatient setting has been
limited, especially in regard to mortality benet. Published in 2016,
a meta-analysis of 4 RCTs with similar inclusion criteria than the
Fig. 3. Forest plot comparing nutritional intervention and control for protein intake. A Mantel-Haenszel random-effects model was used. Squares indicate mean values, with the
size of squares reecting the weigth and the lines indicating.
Fig. 4. Forest plot comparing nutritional intervention and control for caloric intake. A Mantel-Haenszel random-effects model was used. Squares indicate mean values, with the size
of squares reecting the weigth and the lines indicating.
N. Kaegi-Braun, F. Kilchoer, S. Dragusha et al. Clinical Nutrition 41 (2022) 2431e2441
2437
Table 2
Outcomes overall and in subgroups.
Mortality Non-elective
readmissions
Body weight
change [kg]
Weight at
follow up [kg]
BMI-change Function
(hand grip strength)
Daily
protein intake [g]
Daily energy intake [kcal]
OR (95%CI) RR (95%CI) Mean difference
(95%CI)
Mean difference
(95%CI)
Mean difference
(95%CI)
Mean difference
(95%CI)
Mean difference
(95%CI)
Mean difference
(95%CI)
Overall population
Intervention, events/total (%)
or mean (No)
108/1060 (10.2%) 273/823 (33.2%) 1.17 (457) 61.2 (307) 0.37 (118) 20.15 (330) 74.0 (346) 1838.4 (317)
Control, events/total, (%)
or mean (No)
170/1164 (14.6%) 299/820 (36.5%) 0.11 (486) 60.0 (294) 0.45 (101) 20.15 (312) 49.5 (380) 1270.4 (351)
Overall estimate 0.63 (0.48, 0.84) 0.89 (0.74, 1.07) 1.14 (0.58, 1.70) 0.52 (2.36, 1.33) 0.18 (0.75, 1.11) 0.03 (1.08, 1.15) 24.26 (7.18, 41.34) 568.06 (23.56, 1112.57)
Heterogeneity, Test for overall effect I2 ¼1%, p ¼0.001 I2 ¼56%, p ¼0.22 I2 ¼25%, p <0.0001 I2 ¼33%, p ¼0.58 I2 ¼68%, p ¼0.71 I2 ¼62%, p ¼0.95 I2 ¼98%, p ¼0.005 I2 ¼99%, p ¼0.04
Stratication by start of intervention
Start during hospitalisation 0.57 (0.37, 0.86) 0.78 (0.52, 1.15) 0.87 (0.12, 1.61) NA NA NA 13.18 (4.98, 31.35) NA
Start after hospitalisation 0.87 (0.54, 1.39) 0.95 (0.77, 1.17) 1.44 (0.65, 2.23) NA NA NA 32.78 (7.18, 41.34) NA
Test for subgroup differences I2 ¼42.8%, p ¼0.19 I2 ¼0%, p ¼0.38 I2 ¼7.1%, p ¼0.30 NA NA NA I2 ¼15.5%, p ¼0.28 NA
Stratication by type of intervention
Dietary advice ±ONS 0.63 (0.42, 0.94) 0.78 (0.56, 1.10) 1.32 (0.52, 2.12) NA NA NA NA NA
ONS 0.68 (0.42, 1.08) 0.99 (0.91, 1.09) 0.90 (0.02, 1.82) NA NA NA NA NA
Test for subgroup differences I2 ¼0%, p ¼0.81 I2 ¼42.7%, p ¼0.19 I2 ¼0%, p ¼0.50 NA NA NA NA NA
Stratication by duration
of intervention
60 days 0.77 (0.41, 1.44) 0.91 (0.55, 1.51) 0.61 (0.02, 1.24) NA NA NA NA NA
>60 days 0.63 (0.44, 0.90) 0.85 (0.66, 1.10) 1.62 (0.86, 2.38) NA NA NA NA NA
Test for subgroup differences I2 ¼0%, p ¼0.57 I2 ¼0%, p ¼0.81 I2 ¼75.0%, p ¼0.05 NA NA NA NA NA
Stratication by age
Mean age <80 years 0.67 (0.42, 1.09) 0.90 (0.70, 1.17) 1.35 (0.38, 2.32) 1.19 (3.58, 1.20) NA NA 13.20 (-4.16, 30.55) 349.48 (49.39, 748.36)
Mean age >80 years 0.64 (0.38, 1.07) 0.84 (0.61, 1.16) 1.00 (0.27, 1.72) 0.81 (3.77, 5.38) NA NA 32.77 (145, 64.09) 779.87 (252.54, 1812.29)
Test for subgroup differences I2 ¼0%, p ¼0.88 I2 ¼0%, p ¼0.73 I2 ¼0%, p ¼0.57 I2 ¼0%, p ¼0.45 NA NA I2 ¼12.9%, p ¼0.28 I2 ¼0%, p ¼0.45
Stratication by sex
<60% female 0.71 (0.50, 1.01) 0.97 (0.85, 1.10) 0.61 (0.03, 1.19) NA NA NA NA NA
>60% female 0.56 (0.31, 0.88) 0.78 (0.49, 1.25) 1.87 (1.09, 2.66) NA NA NA NA NA
Test for subgroup differences I2 ¼0%, p ¼0.50 I2 ¼0%, 0.38 I2 ¼84.4%, p ¼0.001 NA NA NA NA NA
Stratication by admission diagnosis
Cardial ±pulmonary disease 0.43 (0.28, 0.68) 0.58 (0.25, 1.31) NA NA NA NA NA NA
No specic diagnosis 0.83 (0.59, 1.18) 0.94 (0.75, 1.16) NA NA NA NA NA NA
Test for subgroup differences I2 ¼80.0%, p ¼0.03 I2 ¼20.3%, p ¼0.26 NA NA NA NA NA NA
Stratication by individualized
goals for energy intake
Individualized kcal-goals 0.60 (0.41, 0.90) 0.85 (0.66, 1.10) 1.12 (0.37, 1.87) NA NA NA NA NA
Non-individualized kcal-goals 0.75 (0.45, 1.25) 0.94 (0.74, 1.21) 1.25 (0.34, 2.16) NA NA NA NA NA
Test for subgroup differences I2 ¼0%, p ¼0.53 I2 ¼0%, p ¼0.58 I2 ¼0%, p ¼0.83 NA NA NA NA NA
Amount of protein in the nutritional intervention
High-protein nutritional intervention 0.49 (0.28, 0.86) 0.77 (0.48, 1.23) NA NA NA NA NA NA
Low-protein nutritional intervention 0.78 (0.51, 1.20) 0.87 (0.64, 1.17) NA NA NA NA NA NA
Test for subgroup differences I2 ¼38.3%, p ¼0.20 I2 ¼0%, p ¼0.67 NA NA NA NA NA NA
OR: Odd Ratio, CI: Condence Interval, ONS: oral nutritional supplement, NA: not applicable.
N. Kaegi-Braun, F. Kilchoer, S. Dragusha et al. Clinical Nutrition 41 (2022) 2431e2441
2438
ones of our analysis found no signicant mortality benet[32],
probably due to low number of trials and therefore little power.
Another meta-analysis from 2013 investigating outpatient nutri-
tional support in mixed surgical and medical populations, also did
not nd a signicant mortality reduction [33]. To our knowledge,
this is the largest and, thus, most powerful meta-analysis including
14 RCTs and the rst showing that continued outpatient or post-
discharge nutritional support leads to reduced all-cause mortality
within one year. Our study population was more than three times
larger than in the above mentioned analyses and the quality of
nutrition supplements and individualized therapy has improved
signicantly during the recent years. These could be possible ex-
planations for our new and more positive ndings. We included
trials with different patient populations and different nutritional
interventions resulting in a high external validity.
Additionally, we found that outpatient nutritional therapy was
associated with increased weight gain and nutritional intake,
which could be seen as proof of concept regarding the nutritional
support intervention. These ndings are in line with several other
meta-analyses and reviews from different patient populations
[32e40]. Interestingly, there was no difference in regard to func-
tional improvements measured by handgrip strength. However,
another meta-analysis from 2012, focusing on patients with chronic
obstructive lung disease, found a positive effect of nutritional in-
terventions on handgrip strength, even though the interventions
resulted in lower mean difference of nutritional intake than in our
trial [36]. Moreover, the combination of nutritional support and
physical activity may improve functional outcomes, as shown in a
former meta-analysis of Wright et al. [41].
In case of readmission rates, there was no signicant effect of
nutritional interventions and there was moderate heterogeneity,
probably arising from different durations of intervention and
different diagnoses at admission. An meta-analysis from 2013 re-
ported a signicant reduction of readmission rate [42]. However,
comparability is limited because they included only trials with ONS
and also patients from the community setting without a preceeding
hospitalisation and from any nutritional state. The investigation of
readmission rates and other quality outcomes are important and do
have economic implications for health care systems. There is evi-
dence for the cost-effectiveness of inhospital nutritional support
interventions [43], while there is still a lack of similar studies for the
outpatient malnutrition management.
Furthermore, there is need to determine which specic patient
group benet most from nutritional support. In a subgroup anal-
ysis, we found a pronounced survival benet in patients with car-
diopulmonary diseases. Hence, the underlying disease might play a
role in the extent of the response to nutritional intervention.
Similarly to our ndings, subanalyses of one of the largest RCT from
the inhospital setting, showed strong survival benet of nutritional
support interventions in patients with chronic heart disease [44],
but also for other diseases such as chronic kidney disease [45],
cancer [46], pulmonary infections [47] and frailty [48]. Additionally,
RCTs with >60% women resulted in a higher weight gain than RCTs
with <60% women, but heterogeneity was high. Still patient- or
disease-specic nutritional treatment algorithms could be of in-
terest for further nutritional research. Also, stronger effect of
nutritional interventions on body weight change was found in RCTs
with >60 days duration. This is in line with a recent analysis which
included only hospital-initiated intervention and even found a
signicant difference in mortality risk [49]. Even though not sig-
nicant, results tended to be favorable in the RCTs providing higher
levels of protein and with individualized nutritional requirements,
so characteristics of the nutritional intervention, such as protein
content and quality, individualization and duration of the inter-
vention are considered to be of further interest as well.
5. Limitations
The main limitation of this analysis is the relatively limited
number of trials and patients, reducing the power of our ndings,
especially for subgroups. For many outcomes, heterogeneity was
high among trials and we were not able to create more homoge-
nous subgroups due to low number of eligible studies. Further
search updates including the ongoing trials can be considered in
perspective to update this meta-analysis (eTable 2).
According to the GRADE methodology [50], the quality of evi-
dence was low to very low for most outcomes except for mortality,
weight change, and protein intake where it was moderate. Yet, the
risk of bias analysis showed mostly high risk in performance bias
due to type of intervention and a mixed distribution for detection
and attrition bias.
6. Conclusions
This meta-analysis of randomized-controlled trials with mostly
moderate trial quality suggests that continued outpatient or post-
discharge nutritional support signicantly increases protein and
energy intake as well as body weight, and improves long-term
survival. Further large-scale and high-quality intervention trials
are needed to conrm these ndings and answers further questions
regarding the optimal target population, about duration and quality
of nutritional interventions as well as about their cost-
effectiveness.
Funding
This study was supported in part by the Swiss National Science
Foundation (SNSF Professorship, PP00P3_150531 / 1) and the
Research Council of the Kantonsspital Aarau (1410.000.044).
Author Contributions
NK, FG, and PS wrote the initial protocol. FK, SD, MF, CG and NK
performed the data extraction and performed the statistical ana-
lyses. FK, SD, NK, CG and PS drafted the manuscript; all authors
amended and commented on the manuscript and approved the
nal version. PS oversaw the study and acts as guarantor.
Conict of interest
PS has received research support from Nestl
e Health Science and
Abbott Nutrition and ND received support from Abbott Nutrition
for research and lectures. All other authors conrm that they do not
have a conict of interest associated with this manuscript.
Appendix A. Supplementary data
Supplementary data to this article can be found online at
https://doi.org/10.1016/j.clnu.2022.09.011.
References
[1] FelderS, LechtenboehmerC, Bally M,Fehr R, DeissM, FaesslerL, et al. Associationof
nutritional risk and adverse medical outcomes across different medical inpatient
populations. Nutrition 2015;31(11e12):1385e93. https://doi.org/10.1016/j.nut.
2015.06.007.
[2] Efthymiou A, Hersberger L, Reber E, Schonenberger KA, Kagi-Braun N,
Tribolet P, et al. Nutritional risk is a predictor for long-term mortality: 5-Year
follow-up of the EFFORT trial. Clin Nutr 2021. https://doi.org/10.1016/
j.clnu.2021.02.032.
[3] Deutz NE, Matheson EM, Matarese LE,Luo M, Baggs GE, Nelson JL, et al . Readmission
and mortality in malnourished, older, hospitalizedadults treated with a specialized
N. Kaegi-Braun, F. Kilchoer, S. Dragusha et al. Clinical Nutrition 41 (2022) 2431e2441
2439
oral nutritional supplement: a randomized clinical trial. Research Support, Non-U.S.
Govt. Clin Nutr 2016;35(1):18e26. https://doi.org/10.1016/j.clnu.2015.12.010.
[4] Schuetz P, Fehr R, Baechli V, Geiser M, Deiss M, Gomes F, et al. Individualised
nutritional support in medical inpatients at nutritional risk: a randomised
clinical trial. Lancet 2019;393(10188):2312e21. https://doi.org/10.1016/
S0140-6736(18)32776-4.
[5] Gomes F, Baumgartner A, Bounoure L, Bally M, Deutz NE, Greenwald JL, et al. As-
sociation of nutritional support with clinical outcomes among medical inpatients
who are malnourished or at nutritional risk: an updated systematic review and
meta-analysis. JAMA Netw Open 2019;2(11):e1915138. https://doi.org/10.1001/
jamanetworkopen.2019.15138.
[6] Gomes F, Schuetz P, Bounoure L, Austin P, Ballesteros-Pomar M, Cederholm T,
et al. ESPEN guidelines on nutritional support for polymorbid internal medi-
cine patients. Clin Nutr 2018;37(1):336e53. https://doi.org/10.1016/j.clnu.
2017.06.025.
[7] Kaegi-Braun N, Baumgartner A, Gomes F, Stanga Z, Deutz NE, Schuetz P.
Evidence-based medical nutrition - a difcult journey, but worth the effort!.
Clin Nutr 2020;39(10):3014e8. https://doi.org/10.1016/j.clnu.2020.01.023.
[8] Kaegi-Braun N, Tribolet P, Gomes F, Fehr R, Baechli V, Geiser M, et al.
Six-month outcomes after individualized nutritional support during the
hospital stay in medical patients at nutritional risk: secondary analysis of a
prospective randomized trial. Clin Nutr (Edinb) 2020. https://doi.org/10.
1016/j.clnu.2020.08.019.
[9] Scott A. Screening for malnutrition in the community: the MUST tool. Br J Com-
munity Nurs 2008;13(9):406. https://doi.org/10.12968/bjcn.2008.13.9.30910.408,
410-412.
[10] Cochrane Handbook for systematic reviews of interventions - version 6.3
(updated February 2022). Accessed 29.03.2022. www.training.cochrane.org/
handbook.
[11] Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al.
The PRISMA extension statement for reporting of systematic reviews incor-
porating network meta-analyses of health care interventions: checklist and
explanations. Ann Intern Med 2015;162(11):777e84. https://doi.org/10.7326/
m14-2385.
[12] Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the
median, range, and the size of a sample. BMC Med Res Methodol 2005;5(1):
13. https://doi.org/10.1186/1471-2288-5-13. 2005/04/20.
[13] Higgins JP, Thompson SG, Deeks JJ, AltmanDG. Measuring inconsistency in meta-
analyses. Research Support, Non-U.S. Gov't Review. Bmj 2003;327(7414):557e60.
https://doi.org/10.1136/bmj.327.7414.557.
[14] Cochrane Handbook for systematic reviews of interventions version 5.1.0. The
Cochrane Collaboration; 2020. Updated updated March 2011.
[15] Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guide-
lines on choice of axis. J Clin Epidemiol 2001;54(10):1046e55. https://doi.org/
10.1016/s0895-4356(01)00377-8.
[16] Matheson EM, Nelson JL, Baggs GE, Luo M, Deutz NE. Specialized oral nutri-
tional supplement (ONS) improves handgrip strength in hospitalized,
malnourished older patients with cardiovascular and pulmonary disease: a
randomized clinical trial. Clinical Nutrition 2021;40(3):844e9. https://doi.org/
10.1016/j.clnu.2020.08.035.
[17] Gazzotti C, Arnaud-Battandier F, Parello M, Farine S, Seidel L, Albert A, et al. Pre-
vention of malnutrition in older people during and after hospitalisation: results
from a randomised contro lled clinical trial. Age Ageing 2003;32(3):321 e5. https://
doi.org/10.1093/ageing/32.3.321.
[18] Price R, Daly F, Pennington CR, McMurdo ME. Nutritional supplementation of
very old people at hospital discharge increases muscle strength: a randomised
controlled trial. Randomized Controlled Trial Research Support. Non-U.S.
Gov't. Gerontology 2005;51(3):179e85. https://doi.org/10.1159/000083991.
[19] Sharma Y, Thompson CH, Kaambwa B, Shahi R, Hakendorf P, Miller M.
Investigation of the benets of early malnutrition screening with telehealth
follow up in elderly acute medical admissions. QJM 2017;110(10):639e47.
https://doi.org/10.1093/qjmed/hcx095.
[20] Neelemaat F, Bosmans JE, Thijs A, Seidell JC, van Bokhorst-de van der
Schueren MA. Post-discharge nutritional support in malnourished elderly
individuals improves functional limitations. Randomized Controlled Trial
Research Support, Non-U.S. Gov't. J Am Med Dir Assoc 2011;12(4):295e301.
https://doi.org/10.1016/j.jamda.2010.12.005.
[21] Andersson J, Hulander E, Rothenberg E, Iversen PO. Effect on body weight,
quality of life and appetite following individualized, nutritional counselling to
home-living elderly after rehabilitation - an open randomized trial. J Nutr
Health Aging 2017;21(7):811e8. https://doi.org/10.1007/s12603-016-0825-8.
[22] Yang PH, Lin MC, Liu YY, Lee CL, Chang NJ. Effect of nutritional intervention
programs on nutritional status and readmission rate in malnourished older
adults with pneumonia: a randomized control trial. Int J Environ Res Publ
Health 2019;16(23). https://doi.org/10.3390/ijerph16234758.
[23] Edington J, Barnes R, Bryan F, Dupree E, Frost G, Hickson M, et al. A pro-
spective randomised controlled trial of nutritional supplementation in man-
ourished elderly in the community: clinical and health economic outcomes.
Clinical Nutrition 2004;23(2):195e204. https://doi.org/10.1016/S0261-5614%
2803%2900107-9.
[24] Feldblum I, German L, Castel H, Harman-Boehm I, Shahar DR. Individualized
nutritional intervention during and after hospitalization: the nutrition inter-
vention study clinical trial. J Am Geriatr Soc 2011;59(1):10e7. https://doi.org/
10.1111/j.1532-5415.2010.03174.x.
[25] Beck AM, Kjaer S, Hansen BS, Storm RL, Thal-Jantzen K, Bitz C. Follow-up
home visits with registered dietitians have a positive effect on the functional
and nutritional status of geriatric medical patients after discharge: a ran-
domized controlled trial. Clin Rehabil 2013;27(6):483e93. https://doi.org/
10.1177/0269215512469384.
[26] Beck A. Does adding a dietician to the liaison team after discharge of geriatric
patients improve nutritional outcome: a randomised controlled trial. Clin
Rehabil 2015;29(11):1117e28. https://doi.org/10.1177/0269215514564700.
[27] Munk T, Svendsen JA, Knudsen AW, Ostergaard TB, Thomsen T, Olesen SS,
et al. A multimodal nutritional intervention after discharge improves quality
of life and physical function in older patients - a randomized controlled trial.
Clin Nutr 2021;40(11):5500e10. https://doi.org/10.1016/j.clnu.2021.09.029.
[28] Bonilla-Palomas JL, Gamez-Lopez AL, Castillo-Dominguez JC, Moreno-Conde M,
Lopez Ibanez MC, Alhambra Exposito R, et al. Nutritional intervention in
malnourished hospitalized patients with heart failure. Arch Med Res Oct
2016;47(7):535e40. https://doi.org/10.1016/j.arcmed.2016.11.005.
[29] Feldblum I, German L, Castel H, Harman-Boehm I, Shahar DR. Individualized
nutritional intervention during and after hospitalization: the nutrition inter-
vention study clinical trial. Randomized Controlled Trial Research Support,
Non-U.S. Gov't. J Am Geriatr Soc 2011;59(1):10e7. https://doi.org/10.1111/
j.1532-5415.2010.03174.x.
[30] Baldwin C, de van der Schueren MA, Kruizenga HM, Weekes CE. Dietary
advice with or without oral nutritional supplements for disease-related
malnutrition in adults. Cochrane Database Syst Rev 2021;12(12):Cd002008.
https://doi.org/10.1002/14651858.CD002008.pub5.
[31] Uhl S, Siddique SM, McKeever L, Bloschichak A, DAnci K, Leas B, et al. AHRQ
comparative effectiveness reviews. Malnutrition in hospitalized adults: a sys-
tematic review. Agency for Healthcare Research and Quality (US); 2021.
[32] Munk T, Tolstrup U, Beck AM, Holst M, Rasmussen HH, Hovhannisyan K, et al.
Individualised dietary counselling for nutritionally at-risk older patients
following discharge from acute hospital to home: a systematic review and
meta-analysis. J Hum Nutr Diet 2016;29(2):196e208. https://doi.org/10.1111/
jhn.12307.
[33] Beck AM, Holst M, Rasmussen HH. Oral nutritional support of older (65
yearsþ) medical and surgical patients after discharge from hospital: system-
atic review and meta-analysis of randomized controlled trials. Clin Rehabil
2013;27(1):19e27. https://doi.org/10.1177/0269215512445396.
[34] Vidal Casariego A, Calleja Fernandez A, Villar Taibo R, Maza B, Moreno A,
Cano-Rodríguez I, et al. Efcacy of enteral nutritional support after hospital
discharge in major gastrointestinal surgery patients: a systematic review.
Nutr Hosp 2017;34(3):719e26. https://doi.org/10.20960/nh.482.
[35] Lee JLC, Leong LP, Lim SL. Nutrition intervention approaches to reduce
malnutrition in oncology patients: a systematic review. Support Care Cancer
2016;24(1):469e80. https://doi.org/10.1007/s00520-015-2958-4.
[36] Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive
pulmonary disease: a systematic review and meta-analysis. The American
journal of clinical nutrition 2012;95(6):1385e95. https://doi.org/10.3945/
ajcn.111.023499.
[37] Cawood AL, Elia M, Stratton RJ. Systematic review and meta-analysis of the
effects of high protein oral nutritional supplements. Ageing Res Rev
2012;11(2):278e96. https://doi.org/10.1016/j.arr.2011.12.008.
[38] Baldwin C, Spiro A, Ahern R, Emery PW. Oral n utritional interventions in
malnourished patients with cancer: a systematic review and meta-anal-
ysis. J Natl Cancer Inst 201 2;104(5) :371e85. https://doi.org/10.109 3/jnci/
djr556.
[39] Milne AC, Potter J, Vivanti A, Avenell A. Protein and energy supplementation
in elderly people at risk from malnutrition. Meta-Analysis Review. Cochrane
Database Syst Rev 2009;(2):CD003288. https://doi.org/10.1002/14651858.
CD003288.pub3.
[40] Lidder PG, Lewis S, Duxbury M, Thomas S. Systematic review of postdischarge
oral nutritional supplementation in patients undergoing GI surgery. Nutr Clin
Pract: ofcial publication of the American Society for Parenteral and Enteral
Nutrition 2009;24(3):388e94. https://doi.org/10.1177/0884533609332175.
[41] Wright J, Baldwin C. Oral nutritional support with or without exercise in the
management of malnutrition in nutritionally vulnerable older people: a sys-
tematic review and meta-analysis. Clin Nutr (Edinb) 2018;37(6 Pt A):
1879e91. https://doi.org/10.1016/j.clnu.2017.09.004.
[42] Stratton RJ, Hebuterne X, Elia M. A systematic review and meta-analysis of the
impact of oral nutritional supplements on hospital readmissions. Ageing Res
Rev 2013;12(4):884e97. https://doi.org/10.1016/j.arr.2013.07.002.
[43] Schuetz P, Sulo S, Walzer S, Vollmer L, Brunton C, Kaegi-Braun N, et al. Cost
savings associated with nutritional support in medical inpatients: an eco-
nomic model based on data from a systematic review of randomised trials.
BMJ Open 2021;11(7):e046402. https://doi.org/10.1136/bmjopen-2020-
046402.
[44] Hersberger L, Dietz A, Bürgler H, Bargetzi A, Bargetzi L, Kaegi-Braun N, et al.
Individualized nutritional support for hospitalized patients with chronic heart
failure. J Am Coll Cardiol 2021;77(18):2307e19. https://doi.org/10.1016/
j.jacc.2021.03.232.
[45] Bargetzi A, Emmenegger N, Wildisen S, Nickler M, Bargetzi L, Hersberger L,
et al. Admission kidney function is a strong predictor for the response to
nutritional support in patients at nutritional risk: secondary analysis of a
prospective randomized trial. Clin Nutr 2021. https://doi.org/10.1016/
j.clnu.2021.03.013. 2021/03/15/.
N. Kaegi-Braun, F. Kilchoer, S. Dragusha et al. Clinical Nutrition 41 (2022) 2431e2441
2440
[46] Bargetzi L, Brack C, Herrmann J, Bargetzi A, Hersberger L, Bargetzi M, et al.
Nutritional support during the hospital stay reduces mortality in patients with
different types of cancers: secondary analysis of a prospective randomized
trial. Ann Oncol 2021;32(8):1025e33. https://doi.org/10.1016/j.annonc.2021.
05.793.
[47] Baumgartner A, Hasenboehler F, Cantone J, Hersberger L, Bargetzi A,
Bargetzi L, et al. Effect of nutritional support in patients with lower respiratory
tract infection: secondary analysis of a randomized clinical trial. Clin Nutr
(Edinb) 2020. https://doi.org/10.1016/j.clnu.2020.10.009.
[48] Baumgartner A, Pachnis D, Parra L, Hersberger L, Bargetzi A, Bargetzi L, et al.
The impact of nutritional support on malnourished inpatients with aging-
related vulnerability. Nutrition 2021;89:111279. https://doi.org/10.1016/
j.nut.2021.111279.
[49] Kaegi-Braun N, Faessli M, Kilchoer F, Dragusha S, Tribolet P, Gomes F, et al. Nutri-
tional trials using high protein strategies and long duration of support show
strongest clinical effects on mortality.: results of an updated systematic review and
meta-analysis. Clinical nutrition ESPEN 2021. https://doi.org/10.1016/j.clnesp.
2021.08.003. 2021/08/24/.
[50] Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al.
GRADE: an emerging consensus on rating quality of evidence and strength of
recommendations. BMJ 2008;336(7650):924e6. https://doi.org/10.1136/
bmj.39489.470347 [AD].
[51] Blondal BS, Geirsdottir OG, Halldorsson TI, Beck AM, Jonsson PV, Ramel A.
HOMEFOOD randomised trial esix-month nutrition therapy improves quality
of life, self-rated health, cognitive function, and depression in olderadults after
hospital discharge. Clinical Nutrition ESPEN. doi:10.1016/j.clnesp.2022.01.010.
N. Kaegi-Braun, F. Kilchoer, S. Dragusha et al. Clinical Nutrition 41 (2022) 2431e2441
2441
... A 2022 systematic review highlighted that post-discharge nutrition support reduced mortality in community-dwelling malnourished adults [16]. Interventions included oral nutrition supplementation and/or dietary advice including specific individualised energy and protein intake recommendations [16]. ...
... A 2022 systematic review highlighted that post-discharge nutrition support reduced mortality in community-dwelling malnourished adults [16]. Interventions included oral nutrition supplementation and/or dietary advice including specific individualised energy and protein intake recommendations [16]. Implementation of post-discharge models of care using these effective malnutrition management strategies may help reduce mortality. ...
... Other malnutrition studies have shown similar rates of 18-50% [18,19]. Targeted nutrition interventions for malnourished community-dwelling and residential aged care facility residing older adults may improve nutritional intake and body weight [16,20]. ...
Article
Full-text available
Background/Objectives: Increased mortality and poor post-discharge outcomes are common in malnourished inpatients. It is unknown whether post-discharge outcomes differ between patients with hospital-acquired malnutrition (HAM) or malnutrition present on admission (MPOA), which could impact nutrition processes within healthcare systems and hospital-acquired-complication policy. This retrospective matched case–control study compared mortality, discharge location and readmission at 3-, 12- and 36-months post-discharge between HAM and MPOA patients. Methods: The eligible patients were ≥18 years, malnourished and stayed in hospital for >14 days between 2015 and 2019. HAM patients were 1:1 matched with MPOA patients for age (±3 years), sex, facility and year of admission and further categorised by age group (18 < 65, ≥65 years). The data were obtained from medical records included demographics, mortality, discharge location and readmissions. Statistical tests were used to compare the groups. Results: There were 350 eligible patients (n = 175 HAM, 65 ± 18 years, 37%F, 88% moderately malnourished, 71% from hospitals with >500 beds). HAM and MPOA patients had similar post-discharge mortality (n = 51/175 (29%) vs. n = 64/175 (37%), p > 0.172) and discharge locations (n = 101/111 (81%) vs. n = 91/124 (82%) resided at home, p = 1.00) at 36 months. Of those readmitted to hospital (n= 268/350, 77%), days hospitalised post-discharge (HAM:17(6–40) vs. MPOA:19(8–39)) and number of readmissions (HAM:2(1–4) vs. MPOA:2(1–5)) were similar at 36 months (p > 0.05). However, older MPOA patients were more likely to readmit within 30 days (p = 0.007). Conclusions: Mortality was high but similar between MPOA and HAM patients up to 36 months post-discharge. Discharge location and readmissions were also similar between the groups, except that older MPOA patients were more likely to readmit to hospital within 30 days than older HAM patients. Mechanisms, such as nutrition policies and procedures, implementation of post-discharge nutrition interventions or allocation of post-discharge resources, should be explored further and should consider all long-stay malnourished patients, particularly those aged ≥ 65 years, to reduce preventable patient harm associated with malnutrition.
... One US study found that oral nutrition supplement (ONS) use by communitybased patients receiving home-care significantly lowered healthcare resource utilisation with a corresponding cost reduction of US$1500 per patient. 11 Results of a recent review and meta-analysis showed a significant reduction of mortality by postdischarge nutritional support, 12 and another systematic review revealed that posthospitalisation use of ONS in the community was cost-effective because it produced an overall cost advantage that was often associated with improved clinical outcomes. 13 Further, a budget-impact analysis demonstrated that when a nutrition-focused quality improvement programme was used during and after hospitalisation, the per-patient healthcare utilisation costs were reduced by shortening lengths of hospital stay and by lowering rates of 30-day readmission-a cost reduction amounting to US$3800 per patient. ...
... The estimated population of US older inpatients with malnutrition or at risk of malnutrition 6 was extrapolated to a 2023 level using the population growth rate. Differences in the OR for mortality and the risk ratio for readmission between ONS and non-ONS groups were drawn from a recent meta-analysis of randomised trials by Kaegi-Braun et al. 12 Annual mortality rates from Guenter et al 6 ...
... 36 37 Furthermore, the studies considered in model development recorded chronological age, while this model also generalises to the cohort of patients over 65. This generalisation is consistent with the studies reviewed by Kaegi-Braun et al, 12 most of which focused on patients in the over 65 cohort. Finally, we used data of a meta-analysis of randomised trials to estimate clinical effects. ...
Article
Full-text available
Objective To estimate the health economic value of postdischarge oral nutrition supplement (ONS) consumption among elderly adults who were malnourished during hospitalisation. Design A cost-effectiveness model was developed from a US payer perspective based on a recent meta-analysis of randomised trials of nutritional support following hospital discharge and studies of US hospital mortality, readmission rates and costs. Participants and setting The target population of this study was postacute care US patients aged ≥65 years who were identified as malnourished during hospitalisation. Intervention and outcome measures A decision-tree model was used to evaluate the impact of postacute care daily consumption of ONS compared with no ONS. Outcomes were evaluated over a 1-year time interval. Clinical outcomes of interest included readmission and mortality rates. Economic value of ONS was quantified using three different metrics: cost per death averted, cost per readmission avoided and direct cost savings resulting from changes in postacute mortality and readmission rates. The economic value of ONS was also measured by gains in quality-adjusted life-years. Results Compared with patients not receiving ONS after hospital discharge, use of ONS during the postacute phase reduced mortality by 36.3% and readmissions by 11.0%. Reductions in readmissions resulted in annual savings of US1113perperson.Whenextrapolatingtheresultstotheestimated1693034hospitalisedelderlyUSadultsatriskofmalnutrition,theuseofONSafterhospitaldischargewouldprevent67747deathsand116570hospitalreadmissionsperyear.WiththeestimatedcostofnutritionalsupportatUS1113 per person. When extrapolating the results to the estimated 1 693 034 hospitalised elderly US adults at risk of malnutrition, the use of ONS after hospital discharge would prevent 67 747 deaths and 116 570 hospital readmissions per year. With the estimated cost of nutritional support at US175 per patient per month corresponding to two servings ONS per day, the ONS cost per death and readmission avoided was estimated at US4380andUS4380 and US2546, respectively. Conclusions Postdischarge use of ONS among patients at risk for malnutrition is highly cost-effective with important reductions in mortality and readmission rates.
... A more 'medicalised' dietary approach using liquid oral nutritional supplements in conjunction with maximising the intake of food, can be a useful addition to the toolkit for managing the malnourished person with multiple chronic illnesses in primary care and beyond. A wealth of evidence has shown the value of using oral nutritional supplements, in addition to the diet, improving intake in individuals with a variety of illnesses and diseases (7,(33)(34)(35)(36)(37) . In RCT, ONS typically have little impact on appetite sensations, adding to rather than replacing food intake, and so effectively improving energy, protein and micronutrient intakes (7) . ...
... Wong et al. 2023 (63) recently published an umbrella review and metaanalysis showing that interventions to improve oral intake (including ONS, dietary intake, exercise etc) reduced mortality at 30 d (RR 0·72 (95 % CI 0·55, 0·94), 15 RCT (n 4156)), and at 6 months (RR 0·81 (95 % CI 0·71, 0·92) and one year (RR 0·80 (95 % CI 0·67, 0·95); 27 RCT (n 6387)) compared to placebo/standard care. In polymorbid patients, a systematic review and meta-analysis of 27 trials indicated significantly lower rates of mortality in patients receiving nutritional support whilst acutely ill in hospital (OR, 0·73; 95 % CI 0·56, 0·97)) (36) , with a similar 30 % reduction shown in a more recent larger review of a broader patient group (37) . In the 2019 systematic review of patients with polymorbidity, the sensitivity analyses suggested a more pronounced reduction in risk of mortality in those patients with established malnutrition, in those with greater adherence and in more recent trials (36) . ...
... This review paper indicated the importance of interventions continuing outside of the hospital when patients with polymorbidity have returned home and when benefits can still be evident. Indeed, in malnourished patients given post-discharge nutritional support as outpatients, significantly lower mortality was found from a meta-analysis of 14 RCTs (37) . ...
Article
Full-text available
There are many health and nutrition implications of suffering from multimorbidity, which is a huge challenge facing health and social services. This review focuses on malnutrition, one of the nutritional consequences of multimorbidity. Malnutrition can result from the impact of chronic conditions and their management (polypharmacy) on appetite and nutritional intake, leading to an inability to meet nutritional requirements from food. Malnutrition (undernutrition) is prevalent in primary care and costly, the main cause being disease, accentuated by multiple morbidities. Most of the costs arise from the deleterious effects of malnutrition on individual’s function, clinical outcome and recovery leading to a substantially greater burden on treatment and health care resources, costing at least £19.6 billion in England. Routine identification of malnutrition with screening should be part of the management of multimorbidity together with practical, effective ways of treating malnutrition that overcome anorexia where relevant. Nutritional interventions that improve nutritional intake have been shown to significantly reduce mortality in individuals with multi-morbidities. In addition to food-based interventions, a more ‘medicalised’ dietary approach using liquid oral nutritional supplements (ONS) can be effective. ONS typically have little impact on appetite, effectively improve energy, protein and micronutrient intakes and may significantly improve functional measures. Reduced treatment burden can result from effective nutritional intervention with improved clinical outcomes (fewer infections, wounds), reducing health care use and costs. With the right investment in nutrition and dietetic resources, appropriate nutritional management plans can be put in place to optimally support the multimorbid patient benefitting the individual and the wider society.
... Randomised controlled trials investigating the impact of various post-discharge nutrition interventions have demonstrated significant and clinically relevant increases in mean daily energy and protein intake and body weight [28][29][30], improvements in quality of life [31], and reduced long-term mortality in older adults with or at risk of malnutrition [28]. However, the continuation of nutrition care after hospital discharge depends on the development and dissemination of nutrition-focused discharge plans, effective coordination of the transition of nutrition care post-discharge, and the capability and motivation of patients to participate in this care [32,33]. ...
... Randomised controlled trials investigating the impact of various post-discharge nutrition interventions have demonstrated significant and clinically relevant increases in mean daily energy and protein intake and body weight [28][29][30], improvements in quality of life [31], and reduced long-term mortality in older adults with or at risk of malnutrition [28]. However, the continuation of nutrition care after hospital discharge depends on the development and dissemination of nutrition-focused discharge plans, effective coordination of the transition of nutrition care post-discharge, and the capability and motivation of patients to participate in this care [32,33]. ...
Article
Full-text available
Care transitions from hospital to home for older adults with malnutrition present a period of elevated risk; however, minimal data exist describing the existing practice. This study aimed to describe the transition of nutrition care processes provided to older adults in a public tertiary hospital in Australia. A retrospective chart audit conducted between July and October 2022 included older (≥65 years), malnourished adults discharged to independent living. Dietetic care practices (from inpatient to six-months post-discharge) were reported descriptively. Of 3466 consecutive admissions, 345 (10%) had a diagnosis of malnutrition documented by the dietitian and were included in the analysis. The median number of dietetic visits per admission was 2.0 (IQR 1.0–4.0). Nutrition-focused discharge plans were inconsistently developed and documented. Only 10% of patients had nutrition care recommendations documented in the electronic discharge summary. Post-discharge oral nutrition supplementation was offered to 46% and accepted by 34% of the patients, while only 23% attended a follow-up appointment with dietetics within six months of hospital discharge. Most patients who are seen by dietitians and diagnosed with malnutrition appear lost in transition from hospital to home. Ongoing work is required to explore determinants of post-discharge nutrition care in this vulnerable population.
... Malnourished patients require more assistance with activities of daily living, longer hospital stays, and greater risks of complications and readmissions (3). Furthermore, the mortality rate of patients who received nutritional care after discharge was reduced (4). Sarcopenia and dysphagia, which are both causes and consequences of malnutrition, are also important geriatric syndromes. ...
... Optimizing nutritional screening and assessment and administering individually tailored nutritional preventive or treatment strategies is one of the key principles for managing malnutrition [7,16,38]. Assessing and improving the nutritional status of patients with malnutrition is clinically important, as it helps reduce frailty, enhance physical performance [39], decrease disease-related complications [40], and improve survival [41]. In our study, nutrition screening was performed using the MUST tool. ...
Article
Full-text available
This study investigated the effects of oral nutritional supplements (ONSs) along with dietary counseling (DC) in community-dwelling older adults at risk of malnutrition. In this randomized controlled trial, 196 older adults who were at risk of malnutrition, as identified by the Malnutrition Universal Screening Tool (MUST) were randomly assigned to receive ONSs twice daily with DC (intervention) or DC-only (control) for 60 days. Primary outcome was change in body weight from baseline to day 60. Nutritional status, energy, and macronutrient intakes were measured. A significant larger weight gain was observed in the intervention compared to the control from baseline to day 60 (1.50 ± 0.22 kg, p < 0.0001). The intervention group also showed a significantly greater increase in weight at day 30 (p < 0.0001). Intakes of energy and macronutrients were significantly higher in the intervention group compared to the control group at both days 30 and 60 (all p < 0.0001). The odds of achieving better nutritional status were significantly higher in the intervention group than in the control group (OR:3.9, 95% CI: 1.9, 8.2, p = 0.0001). ONS supplementation combined with DC significantly improved body weight and nutritional outcomes in community-dwelling older adults at risk of malnutrition.
Article
Head and neck cancer and the approaches used to treat it can cause symptoms such as mucositis, alteration or loss of taste, dysphagia, and xerostomia, which makes the incidence of malnutrition in head and neck cancer patients higher than in the general population of cancer patients. Malnutrition in patients with head and neck cancer is associated with the occurrence of treatment-related adverse events, an increase in overall economic cost, a decline in quality of life, and a poor prognosis. Therefore, rehabilitation interventions for malnutrition are necessary throughout the course of the disease. However, the importance of rehabilitation interventions for malnutrition in patients with head and neck cancer has not been fully recognized, and the optimal methods and timing of interventions are unclear. This article provides an overview of rehabilitation interventions for malnutrition, including nutritional supplementation, exercise-based interventions, nutritional counseling and cognitive improvement, and drug therapy, and discusses their advantages and disadvantages as well as potential future directions.
Article
Most every new clinician practicing in nutrition support enters their practice environment with wide open eyes and a sense of curiosity as they encounter new patient and clinical experiences. As clinicians expand their expertise, they often identify challenges they are eager to address. Eagerness turns to passion as the desire to affect change grows. Malnutrition has sparked curiosity and interest in many, and, in some, it has become a passion. As a result, many major achievements have occurred both in the United States and globally that have the capability of moving the needle favorably to achieve better outcomes for our patients. This lecture will highlight how curiosity, eagerness, and passion have led to successes in addressing aspects of malnutrition. These successes offer the structure to continue our efforts to move the needle forward. Our patients deserve nothing more.
Article
Background Malnutrition in hospitalized patients is associated increased length of stay, cost, readmission, and death. No recent studies have examined trends in prevalence or outcomes of hospitalized patients with a diagnosis of malnutrition. Objectives To study the prevalence of malnutrition diagnostic codes and associated hospital outcomes in the United States between 2016 and 2019. Methods We conducted a retrospective trends study to identify use of malnutrition codes in hospitalizations in the National Inpatient Sample between 2016 and 2019. We used direct standardization by logistic regression to adjust outcomes of percutaneous gastrostomy tube placement, mechanical ventilation, and death for age, Gagne comorbidity score, and sex. We then used linear regression to test for trends over time by malnutrition type. Results Across all hospitalizations, codes for diagnoses of non‐severe malnutrition and severe malnutrition were present in 3.7% and 4.1% of hospitalizations, respectively. Codes for any malnutrition increased over time, from 6.6% in 2016 to 8.6% in 2018 ( p = .03). Codes for severe malnutrition increased from 3.3% to 4.7% ( p = .01). Among hospitalizations with coded severe malnutrition diagnoses, there was a statistically significant decrease in adjusted rate of death over time (−0.54% per year, p = .03) which was not seen in hospitalizations without coded malnutrition diagnoses. Conclusions Use of malnutrition diagnosis codes increased significantly from 2016 to 2019. During this time, mortality among hospitalizations with a diagnosis code for severe malnutrition decreased. Though the increased prevalence of malnutrition codes may represent a change in the clinical characteristics of hospitalized patients, the decline in mortality suggests some of the increase may be due to lower threshold for coding and assignment of the diagnosis to less ill patients.
Article
Full-text available
Background and aims Malnutrition is common among older adults and is related to quality of life, cognitive function, and depression. To what extent nutrition interventions can improve these outcomes remains unclear. The aim of this study was to investigate the effect of nutrition therapy on health-related quality of life (EQ-5D), self-rated health, cognitive function, and depression in community dwelling older adults recently discharged from hospital. Methods Participants (>65 years) were randomised into an intervention (n=53) and a control group (n=53). The intervention group received individualised nutrition therapy based on the nutrition care process including 5 home visits and 3 phone calls, in combination with freely delivered energy- and protein-rich foods and oral nutrition supplements for six months after hospital discharge. EQ-5D, self-rated health, Mini-Mental-State-Examination (MMSE), and the Centre for Epidemiologic Studies Depression – IOWA (CES-D) scale were measured at baseline and at endpoint. Results Two subjects dropped out, one from each arm. The control group experienced an increase in depressive symptoms and a decrease in self-rated health during the study period, while the intervention group experienced increases in cognitive function, self-rated health, and EQ-5D resulting in significant endpoint differences between the groups: EQ-5D (0.102, P = 0.001); self-rated health: 15.876, (P < 0.001); MMSE: 1.701, (P < 0.001); depressive symptoms: - 3.072, (P <0.001); all in favour of the intervention group. Improvements during the intervention in MMSE, self-rated health, and CES-D were significantly related to body weight gain in a linear way. Conclusion Cognitive function and mental well-being worsen or stagnate in older adults who receive standard care after hospital discharge. However, a six-month nutrition therapy improves these outcomes leading to statistically and clinically significant endpoint differences between the groups. As improvements were related to body weight gain after hospital discharge, we conclude that the increase in dietary intake, with focus on energy and protein density, and changes in body weight might have contributed to better cognitive function and mental well-being in older adults after the intervention.
Article
Full-text available
Background and aims Nutritional support improves clinical outcomes during hospitalisation as well as after discharge. Recently, a systematic review of 27 randomised, controlled trials showed that nutritional support was associated with lower rates of hospital readmissions and improved survival. In the present economic modelling study, we sought to determine whether in-hospital nutritional support would also return economic benefits. Methods The current economic model applied cost estimates to the outcome results from our recent systematic review of hospitalised patients. In the underlying meta-analysis, a total of 27 trials (n=6803 patients) were included. To calculate the economic impact of nutritional support, a Markov model was developed using transitions between relevant health states. Costs were estimated accounting for length of stay in a general hospital ward, hospital-acquired infections, readmissions and nutritional support. Six-month mortality was also considered. The estimated daily per-patient cost for in-hospital nutrition was US6.23.ResultsOverallcostsofcarewithinthemodeltimeframeof6monthsaveragedUS6.23. Results Overall costs of care within the model timeframe of 6 months averaged US63 227 per patient in the intervention group versus US66045inthecontrolgroup,whichcorrespondstoperpatientcostsavingsofUS66 045 in the control group, which corresponds to per patient cost savings of US2818. These cost savings were mainly due to reduced infection rate and shorter lengths of stay. We also calculated the costs to prevent a hospital-acquired infection and a non-elective readmission, that is, US820andUS820 and US733, respectively. The incremental cost per life-day gained was −US$1149 with 2.53 additional days. The sensitivity analyses for cost per quality-adjusted life day provided support for the original findings. Conclusions For medical inpatients who are malnourished or at nutritional risk, our findings showed that in-hospital nutritional support is a cost-effective way to reduce risk for readmissions, lower the frequency of hospital-associated infections, and improve survival rates.
Article
Full-text available
Background Deterioration of nutritional status during hospitalization in patients with chronic heart failure increases mortality. Whether nutritional support during hospitalization reduces these risks, or on the contrary, may be harmful due to an increase in salt and fluid intake, remains unclear. Objectives The purpose of this trial was to study the effect of nutritional support on mortality in patients hospitalized with chronic heart failure who are at nutritional risk. Methods A total of 645 patients with chronic heart failure (36% [n = 234] with acute decompensation) participated in the investigator-initiated, open-label EFFORT (Effect of early nutritional support on Frailty, Functional Outcomes and Recovery of malnourished medical inpatients) trial. Patients were randomized to protocol-guided individualized nutritional support to reach energy, protein, and micronutrient goals (intervention group) or standard hospital food (control group). The primary endpoint was all-cause mortality at 30 days. Results Mortality over 180 days increased with higher severity of malnutrition (odds ratio per 1-point increase in Nutritional Risk Screening 2002 score: 1.65; 95% confidence interval [CI]: 1.21 to 2.24; p = 0.001). By 30 days, 27 of 321 intervention group patients (8.4%) died, compared with 48 of 324 (14.8%) control group patients (odds ratio: 0.44; 95% CI: 0.26 to 0.75; p = 0.002). Patients at high nutritional risk showed the most benefit from nutritional support. Mortality effects remained significant at 180-day follow-up. Intervention group patients also had a lower risk for major cardiovascular events at 30 days (17.4% vs. 26.9%; odds ratio: 0.50; 95% CI: 0.34 to 0.75; p = 0.001). Conclusions Among hospitalized patients with chronic heart failure at high nutritional risk, individualized nutritional support reduced the risk for mortality and major cardiovascular events compared with standard hospital food. These data support malnutrition screening upon hospital admission followed by an individualized nutritional support strategy in this vulnerable patient population. (Effect of Early Nutritional Therapy on Frailty, Functional Outcomes and Recovery of Undernourished Medical Inpatients Trial [EFFORT]; NCT02517476)
Article
Background: Disease-related malnutrition has been reported in 10% to 55% of people in hospital and the community and is associated with significant health and social-care costs. Dietary advice (DA) encouraging consumption of energy- and nutrient-rich foods rather than oral nutritional supplements (ONS) may be an initial treatment. Objectives: To examine evidence that DA with/without ONS in adults with disease-related malnutrition improves survival, weight, anthropometry and quality of life (QoL). Search methods: We identified relevant publications from comprehensive electronic database searches and handsearching. Last search: 01 March 2021. Selection criteria: Randomised controlled trials (RCTs) of DA with/without ONS in adults with disease-related malnutrition in any healthcare setting compared with no advice, ONS or DA alone. Data collection and analysis: Two authors independently assessed study eligibility, risk of bias, extracted data and graded evidence. Main results: We included 94, mostly parallel, RCTs (102 comparisons; 10,284 adults) across many conditions possibly explaining the high heterogeneity. Participants were mostly older people in hospital, residential care and the community, with limited reporting on their sex. Studies lasted from one month to 6.5 years. DA versus no advice - 24 RCTs (3523 participants) Most outcomes had low-certainty evidence. There may be little or no effect on mortality after three months, RR 0.87 (95% confidence interval (CI) 0.26 to 2.96), or at later time points. We had no three-month data, but advice may make little or no difference to hospitalisations, or days in hospital after four to six months and up to 12 months. A similar effect was seen for complications at up to three months, MD 0.00 (95% CI -0.32 to 0.32) and between four and six months. Advice may improve weight after three months, MD 0.97 kg (95% CI 0.06 to 1.87) continuing at four to six months and up to 12 months; and may result in a greater gain in fat-free mass (FFM) after 12 months, but not earlier. It may also improve global QoL at up to three months, MD 3.30 (95% CI 1.47 to 5.13), but not later. DA versus ONS - 12 RCTs (852 participants) All outcomes had low-certainty evidence. There may be little or no effect on mortality after three months, RR 0.66 (95% CI 0.34 to 1.26), or at later time points. Either intervention may make little or no difference to hospitalisations at three months, RR 0.36 (95% CI 0.04 to 3.24), but ONS may reduce hospitalisations up to six months. There was little or no difference between groups in weight change at three months, MD -0.14 kg (95% CI -2.01 to 1.74), or between four to six months. Advice (one study) may lead to better global QoL scores but only after 12 months. No study reported days in hospital, complications or FFM. DA versus DA plus ONS - 22 RCTs (1286 participants) Most outcomes had low-certainty evidence. There may be little or no effect on mortality after three months, RR 0.92 (95% CI 0.47 to 1.80) or at later time points. At three months advice may lead to fewer hospitalisations, RR 1.70 (95% CI 1.04 to 2.77), but not at up to six months. There may be little or no effect on length of hospital stay at up to three months, MD -1.07 (95% CI -4.10 to 1.97). At three months DA plus ONS may lead to fewer complications, RR 0.75 (95% CI o.56 to 0.99); greater weight gain, MD 1.15 kg (95% CI 0.42 to 1.87); and better global QoL scores, MD 0.33 (95% CI 0.09 to 0.57), but this was not seen at other time points. There was no effect on FFM at three months. DA plus ONS if required versus no advice or ONS - 31 RCTs (3308 participants) Evidence was moderate- to low-certainty. There may be little or no effect on mortality at three months, RR 0.82 (95% CI 0.58 to 1.16) or at later time points. Similarly, little or no effect on hospitalisations at three months, RR 0.83 (95% CI 0.59 to 1.15), at four to six months and up to 12 months; on days in hospital at three months, MD -0.12 (95% CI -2.48 to 2.25) or for complications at any time point. At three months, advice plus ONS probably improve weight, MD 1.25 kg (95% CI 0.73 to 1.76) and may improve FFM, 0.82 (95% CI 0.35 to 1.29), but these effects were not seen later. There may be little or no effect of either intervention on global QoL scores at three months, but advice plus ONS may improve scores at up to 12 months. DA plus ONS versus no advice or ONS - 13 RCTs (1315 participants) Evidence was low- to very low-certainty. There may be little or no effect on mortality after three months, RR 0.91 (95% CI 0.55 to 1.52) or at later time points. No study reported hospitalisations and there may be little or no effect on days in hospital after three months, MD -1.81 (95% CI -3.65 to 0.04) or six months. Advice plus ONS may lead to fewer complications up to three months, MD 0.42 (95% CI 0.20 to 0.89) (one study). Interventions may make little or no difference to weight at three months, MD 1.08 kg (95% CI -0.17 to 2.33); however, advice plus ONS may improve weight at four to six months and up to 12 months. Interventions may make little or no difference in FFM or global QoL scores at any time point. Authors' conclusions: We found no evidence of an effect of any intervention on mortality. There may be weight gain with DA and with DA plus ONS in the short term, but the benefits of DA when compared with ONS are uncertain. The size and direction of effect and the length of intervention and follow-up required for benefits to emerge were inconsistent for all other outcomes. There were too few data for many outcomes to allow meaningful conclusions. Studies focusing on both patient-centred and healthcare outcomes are needed to address the questions in this review.
Article
Background Many older hospitalized patients are at nutritional risk or malnourished and the nutritional condition is often further impaired during hospitalization. When discharged to own home, a "Nutrition Gap" often occurs, causing inadequate dietary intake, and potentially impeded recovery. Previously, cross-sectorial studies of single component nutritional intervention have shown a limited effect on clinically relevant outcomes. We hypothesized that a multimodal nutritional intervention is necessary to elicit a beneficial effect on clinically relevant outcomes. Methods A randomized controlled trial was performed for a period of 16 weeks. At discharge, the intervention group (IG) received dietetic counselling including a recommendation of daily training, an individual nutrition plan and a package containing foods and drinks covering dietary requirements for the next 24 hours. Further, a goodie-bag containing samples of protein-rich milk-based drinks were provided. Information regarding recommendations of nutritional therapy after discharge was systematically and electronically communicated to the municipality. The dietician performed telephone follow-ups on day 4 and 30 and a home visit at 16 weeks. The control group (CG) received standard treatment. The primary outcome was readmissions within 6 month, secondary outcomes were Length of Stay (LOS), Health Related Quality of Life (EQ-5D-3L), nutritional status, physical function (30s-CST) and mortality. This trial was registered under ClinicalTrials.gov Identifier no. NCT03488329. Results We included 191 patients (IG: n=93). No significant difference was seen in readmissions within 6 month (IG: 45% vs. CG: 45%, Risk Ratio (RR): 0.96 0.71-1.31, p=0.885). At the 16-weeks follow-up more patients in the IG reached at least 75% of energy and protein requirements (82 % vs. CG: 61 %, p=0,007). The energy (kcal) and protein intake (g) per kg was significantly higher in the IG (26.4 kcal/kg (±7.4) vs. 22.6 (±7.4), p=0.0248) (1.1 g/kg (±0.3) vs. 0.9g/kg (±0.3). Furthermore, significant lower weight loss was seen in IG (0.7 (±4.3) vs. -1.4 (±3.6), p=0.002). A significant and clinically relevant difference was found in the EQ-5D-3L VAS-score (IG: mean 61.6 ±16.2 vs. CG: 53.3 ±19.3, p=0.011)(Δ14.3 (±15.5) vs. Δ5.6 (±17.2), p=0.002). A significant difference in mean 30s-CST in IG was also found (7.2 (±4.3) vs. 5.3 (±4.1), p=0.010). The improvements in physical function were of clinical relevance in both groups, but significantly higher in the IG (Δ4.2 (±4.4) vs. Δ2.2 (±2.5), p=0.008). In fact, 86% in IG experienced improvements in the 30s-CST compared with 68% in the CG (p=0.022). LOS was found to be lower at all time points, however not significant (30 days: -3 (-8.5 to 2.5), p=0.276, 16 weeks: -4 (-10.2 to 2.2, p=0.204), 6 months: -3 (-9.3 to 3.3, p=0346)),. All-cause mortality was not different between groups, however RR showed a non-significantly 47 % reduction at day 30 (0.53 (0.14 to 2.05, p=0.499)) and a 17 % reduction at 16 weeks (0.83 (0.40 to 1.73, p=1.000)) in IG. Per protocol (PP) analysis revealed a non-significant decrease of 32 % in readmission at 6 months (RR: 0.68 (0.42 to 1.08), p=0.105). Conclusion The present study, using a multimodal nutritional approach, revealed no significant effect on readmissions however a significant positive effect on nutritional status, quality of life and physical function was found. The improvements in quality of life and physical function were of clinical relevance. No significant effect was foundon LOS and mortality.
Article
Background There is increasing evidence from randomized-controlled trials demonstrating that nutritional support improves clinical outcomes in the population of malnourished medical inpatients. We investigated associations of trial characteristics including clinical setting, duration of intervention, individualization of nutritional support and amount of energy and protein, and effects on clinical outcomes in an updated meta-analysis. Methods We searched Cochrane Library, MEDLINE and EMBASE, from inception to December 15, 2020. Randomized-controlled trials investigating the effect of oral and enteral nutritional support interventions, when compared to usual care, on clinical outcomes of malnourished non-critically ill medical inpatients were included. Two reviewers independently extracted data and assessed risk of bias. The primary endpoint was all cause-mortality within 12-months. Results We included 29 randomized-controlled trials with a total of 7,166 patients. Heterogeneity across RCTs was high, with overall moderate study quality and mostly moderate or unclear risk of bias. Overall, there was an almost 30%-reduction in mortality in patients receiving nutritional support compared to patients not receiving nutritional support (253/2960 [8.5%] vs. 336/2976 [11.3%]) with an odds ratio of 0.72 (95% CI 0.57 to 0.91, p=0.006). The most important predictors for the effect of nutritional trials on mortality were high protein strategies (odds ratio 0.57 vs. 0.93, I²=86.3%, p for heterogenity=0.007) and long-term nutritional interventions (odds ratio 0.53 vs. 0.85, I²=76.2%, p for heterogenity=0.040). Nutritional support also reduced unplanned hospital readmissions and length of hospital stay. Conclusions There is increasing evidence from randomized trials showing that nutritional support significantly reduces mortality, unplanned hospital readmissions and length of stay in medical inpatients at nutritional risk, despite heterogeneity and varying methodological quality among trials. Trials with high-protein strategies and long-lasting nutritional support interventions were most effective.
Article
Objectives Malnutrition is highly prevalent in patients with aging-related vulnerability defined by very old age (≥80 y), physical frailty or cognitive impairment, and increases the risks for morbidity and mortality. The effects of individualized nutritional support for patients with aging-related vulnerability in the acute hospital setting on mortality and other clinical outcomes remains understudied. Methods For this secondary analysis of the randomized-controlled Effect of Early Nutritional Support on Frailty, Functional Outcomes, and Recovery of Malnourished Medical Inpatients Trial (EFFORT), we analyzed data of patients at a nutritional risk (Nutritional Risk Screening 2002 score ≥3 points) with aging-related vulnerability, randomized to receive protocol-guided individualized nutritional support to reach specific protein and energy goals (intervention group) or routine hospital food (control group). The primary endpoint was all-cause 30-d mortality. Results Of the 881 patients with aging-related vulnerability, 23.4% presented with a frailty syndrome, 81.8% were age ≥80 y and 15.3% showed cognitive impairment. Patients with aging-related vulnerability receiving individualized nutritional support compared with routine hospital food showed a >50% reduction in the risk of 30-day mortality (60 of 442 [13.6%] versus 31 of 439 [7.1%]; odds ratio: 0.48; 95% confidence interval, 0.31–0.76; P = 0.002). Significant improvements were also found for long-term mortality at 180 days, as well as functional outcomes and quality of life measures. Conclusions Malnourished patients with aging-related vulnerability show a significant and clinically relevant reduction in the risk of mortality and other adverse clinical outcomes after individualized in-hospital nutritional support compared to routine hospital nutrition. These data support the early screening of patients with aging-related vulnerability for nutritional risk, followed by a nutritional assessment and implementation of individualized nutritional interventions.
Article
Introduction Nutritional support in patients with cancer aims at improving quality of life. Whether use of nutritional support is also effective in improving clinical outcomes remains understudied. Methods In this preplanned secondary analysis of patients with cancer included in a prospective, randomized-controlled, Swiss, multicenter trial (EFFORT), we compared protocol-guided individualized nutritional support (intervention group) to standard hospital food (control group) regarding mortality at 30-day (primary endpoint) and other clinical outcomes. Results We analyzed 506 patients with a main admission diagnosis of cancer, including lung cancer (n=113), gastrointestinal tumors (n=84), hematological malignancies (n=108) and other types of cancer (n=201). Nutritional risk based on Nutritional Risk Screening [NRS 2002] was an independent predictor for mortality over 180 days with a (age-, sex-, center-, type of cancer-, tumor activity- and treatment-) adjusted hazard ratio of 1.29 (95% CI 1.09 to 1.54; p=0.004) per point increase in NRS. In the 30-day follow-up period, 50 patients (19.9%) died in the control group compared to 36 (14.1%) in the intervention group resulting in an adjusted odds ratio of 0.57 (95% CI 0.35 to 0.94; p=0.027). Interaction tests did not show significant differences in mortality across the cancer type subgroups. Nutritional support also significantly improved functional outcomes and quality of life measures. Conclusion Compared to usual hospital nutrition without nutrition support, individualized nutritional support reduced the risk for mortality and improved functional and quality of life outcomes in cancer patients with increased nutritional risk. These data further support the inclusion of nutritional care in cancer management guidelines.
Article
Background Patients with chronic kidney disease (CKD) are at substantial risk of malnutrition, which negatively affects clinical outcomes. We investigated the association of kidney function assessed at hospital admission and effectiveness of nutritional support in hospitalized medical patients at risk of malnutrition. Methods This is a secondary analysis of an investigator-initiated, randomized-controlled, Swiss multicenter trial (EFFORT) that compared individualised nutritional support with usual hospital food on clinical outcomes. We compared effects of nutritional support on mortality in subgroups of patients stratified according to kidney function at the time of hospital admission (estimated glomerular filtration rates [eGFR] <15, 15-29, 30-59, 60-89 and ≥90 ml/min/1.73m²). Results We included 1,943 of 2,028 patients (96%) from the original trial with known admission creatinine levels. Admission eGFR was a strong predictor for the beneficial effects of nutritional support in regard to lowering of 30-day mortality. Patients with an eGFR <15, 15-29 and 30-59 had the strongest mortality benefit (odds ratios [95%CI] of 0.24 [0.05 to 1.25], 0.37 [0.14 to 0.95] and 0.39 [0.21 to 0.75], respectively), while patients with less severe impairment in kidney function had a less pronounced mortality benefits (p for interaction 0.001). A similar stepwise association of kidney function and response to nutritional support was found also for other secondary outcomes. Conclusion In medical inpatients at nutritional risk, admission kidney function was a strong predictor for the response to nutritional therapy. Initial kidney function thus may help to individualize nutritional support in the future by identification of patients with most clinical benefit. Clinical trial registration Registered under ClinicalTrials.gov Identifier no. NCT02517476.
Article
Background and aims The nutritional risk screening (NRS 2002) is a validated screening tool for malnutrition. This study aims to investigate the prognostic value of the NRS 2002 and its individual components regarding long-term mortality and adverse outcomes in a well-characterized cohort of medical inpatients. Methods We performed a 5-year follow-up investigation of patients included in the investigator-initiated, prospective, randomized controlled multicenter EFFORT trial that evaluated the effects of individualized nutritional intervention vs. standard hospital food. We used multivariable cox regression analyses adjusted for randomisation arm, study centre, comorbidities and main diagnosis to investigate associations between NRS 2002 total scores at time of hospital admission and several long-term outcomes. Results We had confirmed mortality data over the mean follow-up time of 3.2 years in 1,874 from the initial 2,028 patients included in the original trial. Mortality showed a step-wise increase in patients with NRS 3 (289/565 [51.2%]) and NRS 4 (355/717 [49.6%]) to 59.5% (353/593) in patient with NRS≥5 corresponding to an adjusted Hazard Ratio (HR) of 1.28 (95%CI 1.15 to 1.42, p≤0.001) for mortality after one year and 1.13 (95%CI 1.05 to 1.23, p=0.002) for the overall time period. All individual components of NRS including disease severity, food intake, weight loss and BMI provided prognostic information regarding long-term mortality risk. Conclusion Nutritional risk mirrored by a NRS 2002 total score is a strong and independent predictor of long‐term mortality in polymorbid medical inpatients particularly if patients have ≥5 points.